1. Home
  2. RBC vs CORT Comparison

RBC vs CORT Comparison

Compare RBC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBC
  • CORT
  • Stock Information
  • Founded
  • RBC 1919
  • CORT 1998
  • Country
  • RBC United States
  • CORT United States
  • Employees
  • RBC N/A
  • CORT N/A
  • Industry
  • RBC Metal Fabrications
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBC Industrials
  • CORT Health Care
  • Exchange
  • RBC Nasdaq
  • CORT Nasdaq
  • Market Cap
  • RBC 9.7B
  • CORT 8.1B
  • IPO Year
  • RBC 2005
  • CORT N/A
  • Fundamental
  • Price
  • RBC $372.92
  • CORT $71.38
  • Analyst Decision
  • RBC Buy
  • CORT Strong Buy
  • Analyst Count
  • RBC 6
  • CORT 4
  • Target Price
  • RBC $390.20
  • CORT $142.00
  • AVG Volume (30 Days)
  • RBC 161.2K
  • CORT 1.4M
  • Earning Date
  • RBC 08-01-2025
  • CORT 07-28-2025
  • Dividend Yield
  • RBC N/A
  • CORT N/A
  • EPS Growth
  • RBC 20.13
  • CORT 8.36
  • EPS
  • RBC 7.70
  • CORT 1.14
  • Revenue
  • RBC $1,636,300,000.00
  • CORT $685,446,000.00
  • Revenue This Year
  • RBC $8.90
  • CORT $35.85
  • Revenue Next Year
  • RBC $7.91
  • CORT $35.22
  • P/E Ratio
  • RBC $48.25
  • CORT $62.59
  • Revenue Growth
  • RBC 4.87
  • CORT 30.93
  • 52 Week Low
  • RBC $260.53
  • CORT $28.10
  • 52 Week High
  • RBC $386.41
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • RBC 57.22
  • CORT 48.38
  • Support Level
  • RBC $363.05
  • CORT $69.60
  • Resistance Level
  • RBC $375.31
  • CORT $73.13
  • Average True Range (ATR)
  • RBC 7.97
  • CORT 3.50
  • MACD
  • RBC -1.73
  • CORT -0.18
  • Stochastic Oscillator
  • RBC 56.41
  • CORT 24.77

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The end market is the United States of America. The company has two reportable segments: Aerospace Defense segment represents the end markets for the company's highly engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and Industrial segment represents the end markets for the company's engineered bearings and precision components used in various industrial applications. It derives maximum revenue from Industrial Segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: